Sales and Marketing

Showing 15 posts of 11524 posts found.

bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …
nurofen

Nurofen maker hit by $6m fine over “misleading conduct”

December 16, 2016 Sales and Marketing Nurofen, Reckitt Benckiser

After a case last year levied by the Australian Federal Court over “misleading conduct” concerning the marketing of its branded …

Actavis UK overcharged NHS with 12,000% price hike, watchdog says

December 16, 2016 Medical Communications, Sales and Marketing Actavis, CMA, NHS

Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 16, 2016 Medical Communications, Sales and Marketing NICE

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

Pfizer’s next blockbuster given FDA approval

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …
digital_pharma

NICE and FDA to collaborate in medtech access scheme

December 15, 2016 Medical Communications, Sales and Marketing FDA, NICE

The National Institute of Health and Care Excellence (NICE) and the US Food and Drugs Administration (FDA) have announced their …
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …
shutterstock_92671375

Five major pharma firms break ABPI code of conduct, according to watchdog

December 15, 2016 Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen

Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …
ritalin-sr-20mg-1000x1000

35% of all imported medicine in Guyana is fake, investigation finds

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …
actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …

Lilly offers insulin at 40% discount

December 13, 2016 Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
jevtana_0

Scottish Medicines Consortium approves Sanofi’s prostate cancer drug

December 12, 2016 Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
The Gateway to Local Adoption Series

Latest content